Search Results - "Vietti, T"

Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study by SAYLORS, Robert L, STINE, Kimo C, SULLIVAN, Jim, KEPNER, James L, WALL, Donna A, BERNSTEIN, Mark L, HARRIS, Michael B, HAYASHI, Robert, VIETTI, Teresa J

“…To determine the response rate of the combination of cyclophosphamide and topotecan in pediatric patients with recurrent or refractory malignant solid tumors…”
Get full text

Low-Stage Medulloblastoma: Final Analysis of Trial Comparing Standard-Dose With Reduced-Dose Neuraxis Irradiation by THOMAS, P. R. M, DEUTSCH, M, MULHERN, R, STEHBENS, J. A, LANGSTON, J, STANLEY, P, DUFFNER, P, RORKE, L, CHERLOW, J, FRIEDMAN, H. S, FINLAY, J. L, VIETTI, T. J, KEPNER, J. L, KUN, L. E, BOYETT, J. M, KRISCHER, J, ARONIN, P, ALBRIGHT, L, ALLEN, J. C, PACKER, R. J, LINGGOOD, R

“…To evaluate prospectively the effects on survival, relapse-free survival, and patterns of relapse of reduced-dose (23.4 Gy in 13 fractions) compared with…”
Get full text

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone by Grier, Holcombe E, Krailo, Mark D, Tarbell, Nancy J, Link, Michael P, Fryer, Christopher J.H, Pritchard, Douglas J, Gebhardt, Mark C, Dickman, Paul S, Perlman, Elizabeth J, Meyers, Paul A, Donaldson, Sarah S, Moore, Sheila, Rausen, Aaron R, Vietti, Teresa J, Miser, James S

“…Ewing's sarcoma, a highly malignant tumor of children, adolescents, and young adults, often responds to local excision plus a now-standard four-drug regimen of…”
Get full text

Up-Front Window Trial of Topotecan in Previously Untreated Children and Adolescents With Metastatic Rhabdomyosarcoma: An Intergroup Rhabdomyosarcoma Study by PAPPO, Alberto S, LYDEN, Elizabeth, BRENEMAN, John, WIENER, Eugene, TEOT, Lisa, MEZA, Jane, CRIST, William, VIETTI, Teresa

“…To investigate the antitumor activity and toxicity of topotecan, used alone and in combination with conventional therapy, in patients with metastatic…”
Get full text

Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype : the Pediatric Oncology Group experience by NAVID, F, MOSIJCZUK, A. D, SHIELDS, D. J, VIETTI, T. J, PULLEN, D. J, HEAD, D. R, BOROWITZ, M. J, CARROLL, A. J, BRANDT, J. M, LINK, M. P, ROZANS, M. K, THOMAS, G. A, SCHWENN, M. R

“…Five pediatric patients are described with acute lymphoblastic leukemia (ALL) who at presentation had clinical findings suggestive of B cell ALL and…”
Get full text

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study by Saylors, 3rd, R L, Stewart, C F, Zamboni, W C, Wall, D A, Bell, B, Stine, K C, Vietti, T J

“…To determine the maximum-tolerated dose (MTD) and dose-limiting toxicity of topotecan when combined with cyclophosphamide in pediatric patients with recurrent…”
Get more information

Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study by Nesbit, Jr, M E, Gehan, E A, Burgert, Jr, E O, Vietti, T J, Cangir, A, Tefft, M, Evans, R, Thomas, P, Askin, F B, Kissane, J M

“…A total of 342 previously untreated eligible children were entered into the first Intergroup Ewing's Sarcoma Study (IESS) between May 1973 and November 1978…”
Get more information

Poor Prognosis of Children With Pre-B Acute Lymphoblastic Leukemia Is Associated With the t(l;19)(q23;pl3): A Pediatric Oncology Group Study by Crist, W.M., Carroll, A.J., Shuster, J.J., Behm, F.G., Whitehead, M., Vietti, T.J., Look, A.T., Mahoney, D., Ragab, A., Pullen, D.J., Land, V.J.

“…The prognostic significance of chromosomal translocations, particularly t(1;19) (q23;p13), was evaluated in children with pre-B and early pre-B acute…”
Get full text

The Third Intergroup Rhabdomyosarcoma Study by Crist, W, Gehan, E A, Ragab, A H, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J, Heyn, R

“…The ultimate goal of the Third Intergroup Rhabdomyosarcoma Study (IRS-III, 1984 to 1991) was to improve treatment outcome in children with rhabdomyosarcoma…”
Get more information

Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II by Burgert, Jr, E O, Nesbit, M E, Garnsey, L A, Gehan, E A, Herrmann, J, Vietti, T J, Cangir, A, Tefft, M, Evans, R, Thomas, P

“…Two hundred fourteen eligible patients with previously untreated, localized Ewing's sarcoma of bone were randomized on IESS-II to receive Adriamycin (ADR;…”
Get more information

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors : A Pediatric Oncology Group Study by TUBERGEN, D. G, STEWART, C. F, VIETTI, T. J, PRATT, C. B, ZAMBONI, W. C, WINICK, N, SANTANA, V. M, DRYER, Z. A, KURTZBERG, J, BELL, B, GRIER, H

“…A phase I trial was conducted in children with refractory solid tumors to determine the maximum tolerated dose (MTD), dose-limiting toxicity (DLT),…”
Get full text

Preservation of the bladder in patients with rhabdomyosarcoma by Heyn, R, Newton, W A, Raney, R B, Hamoudi, A, Bagwell, C, Vietti, T, Wharam, M, Gehan, E, Maurer, H M

“…To review the pathologic findings from children with gross residual rhabdomyosarcoma (RMS) of the bladder and compare the treatment outcome of those who…”
Get more information

Conduct of phase I trials in children with cancer by Smith, M, Bernstein, M, Bleyer, W A, Borsi, J D, Ho, P, Lewis, I J, Pearson, A, Pein, F, Pratt, C, Reaman, G, Riccardi, R, Seibel, N, Trueworthy, R, Ungerleider, R, Vassal, G, Vietti, T

“…Future progress in the care of children with cancer requires appropriate evaluations of promising new agents for pediatric indications, beginning with…”
Get more information

Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study by Hurwitz, C A, Relling, M V, Weitman, S D, Ravindranath, Y, Vietti, T J, Strother, D R, Ragab, A H, Pratt, C B

“…A phase I study was performed to describe the principal toxicities and identify the maximum-tolerated dose (MTD) of Taxol (paclitaxel; Bristol-Myers Squibb Co,…”
Get more information

Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study by Evans, R G, Nesbit, M E, Gehan, E A, Garnsey, L A, Burgert, Jr, O, Vietti, T J, Cangir, A, Tefft, M, Thomas, P, Askin, F B

“…A total of 59 eligible patients with localized Ewing's sarcoma of the pelvic and sacral bones were entered into a multimodal Intergroup Ewing's Sarcoma Study…”
Get more information

Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma by Haas, J E, Muczynski, K A, Krailo, M, Ablin, A, Land, V, Vietti, T J, Hammond, G D

“…To determine the relationship between outcome and histologic type, the authors examined data from 168 cases of hepatoblastoma (HB) and 28 cases of…”
Get more information

The Intergroup Rhabdomyosarcoma Study-II by Maurer, H M, Gehan, E A, Beltangady, M, Crist, W, Dickman, P S, Donaldson, S S, Fryer, C, Hammond, D, Hays, D M, Herrmann, J

“…Intergroup Rhabdomyosarcoma Study (IRS)-II, (1978-1984) had the general goals of improving the survival and treatment of children with rhabdomyosarcoma (RMS)…”
Get more information

Risk factors for Wilms tumor. Report from the National Wilms Tumor Study by Olshan, A F, Breslow, N E, Falletta, J M, Grufferman, S, Pendergrass, T, Robison, L L, Waskerwitz, M, Woods, W G, Vietti, T J, Hammond, G D

“…Previous epidemiologic studies have indicated that several factors may be associated with an increased risk of Wilms tumor including paternal occupational…”
Get more information

Clinical Features and Outcome in Childhood T-Cell Leukemia-Lymphoma According to Stage of Thymocyte Differentiation: A Pediatric Oncology Group Study by Crist, William M., Shuster, Jonathan J., Falletta, John, Pullen, D.J., Berard, C.W., Vietti, T.J., Alvarado, Carlos S., Roper, Mary Ann, Prasthofer, Ed, Grossi, Carlo E.

“…The immunophenotypes of lymphoblasts from children with newly diagnosed T-cell acute lymphoid leukemia IT-ALL, n = 101) or T-cell non-Hodgkin lymphoma (T-NHL,…”
Get full text

The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia : a pediatric oncology group study by CARROLL, A. J, CRIST, W. M, LINK, M. P, AMYLON, M. D, PULLEN, D. J, RAGAB, A. H, BUCHANAN, G. R, WIMMER, R. S, VIETTI, T. J

“…We report the nonrandom occurrence, frequency, and degree of immunophenotype association of the t(1;14)(p34;q11) in children with acute lymphoblastic leukemia…”
Get full text